DocMorris AG (VTX:DOCM) shareholders should be happy to see the share price up 10% in the last month. But the last three years have seen a terrible decline. To wit, the share price sky-dived 90% in ...

Sales of prescription medicines (Rx) grew year-on-year in July Monthly number of new Rx customers quadrupled Break-even achieved excluding eRx in the first half of 2024 Outlook 2024 reduced CardLink ...

DocMorris AG (VTX:DOCM) shareholders should be happy to see the share price up 15% in the last month. But that doesn't change the fact that the returns over the last half decade have been stomach ...

Tripling of new Rx customers since the introduction of CardLink Doubling and continuous increase in eRx market share since January 2024 17 per cent revenue growth of prescription medicines (Rx) ...

March 21 (Reuters) - Swiss online drug retailer DocMorris AG (DOCM.S), opens new tab could make a core loss of up to 35 million Swiss francs ($39.6 million) in 2024, it said on Thursday, warning ...

Good morning, everyone, and welcome to our Q1 '26 trading update. I'm Walter Hess, the CEO, and I'm joined today by our CFO, Daniel Wuest. In line with what we announced at the full year conference, ...

Despite strong growth in e-prescriptions, DocMorris is making high losses, but the company hopes to make a profit this year thanks to e-prescriptions. This is stated in a letter from DocMorris to ...

Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Frauenfeld, 17 August 2023 Press release Ad hoc announcement pursuant to ...

DocMorris (DOCM) has delivered a 44.44% change over the past year, with a 52-week range between 3.92 and 9.25. What Is the Average Daily Trading Volume of DocMorris (DOCM)? The average daily trading ...

Aug 17 (Reuters) - Swiss online drug retailer DocMorris (DOCM.S), opens new tab on Thursday reported a first-half adjusted core loss roughly in line with expectations, a result boosted by the ...